These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4850602)

  • 1. Anticonvulsant properties of cannabidiol.
    Turkanis SA; Cely W; Olsen DM; Karler R
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):231-46. PubMed ID: 4850602
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):23-39. PubMed ID: 4438826
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):441-52. PubMed ID: 4548551
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic interactions of albutoin with other anticonvulsant drugs.
    Wallin RF; Blackburn WH; Napoli MD
    J Pharmacol Exp Ther; 1970 Aug; 174(2):276-82. PubMed ID: 5451364
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine.
    Dwivedi C; Harbison RD
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):452-8. PubMed ID: 1145630
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the anticonvulsant properties of 2-diethylaminopento-4-ynoyl-2',6'-xylidide (WY 21745) with lignocaine, phenytoin, phenobarbitone and trimethadione.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):405-14. PubMed ID: 5559826
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of the effects of 9 -tetrahydrocannabinol by phenobarbital pretreatment in mice.
    Fujimoto JM
    Toxicol Appl Pharmacol; 1972 Dec; 23(4):623-34. PubMed ID: 4644697
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
    Consroe P; Martin P; Eisenstein D
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):1-13. PubMed ID: 841172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    J Pharmacol Exp Ther; 1981 Jun; 217(3):805-11. PubMed ID: 7230008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.
    Chiu P; Karler R; Craven C; Olsen DM; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):267-86. PubMed ID: 1197914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant testing with a new analeptic convulsant: N-sulfamoyl-hexahydro-azepine (Sah 41-178).
    Iorio LC; Ryan EA; Gogerty JH
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):282-7. PubMed ID: 4149788
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of seizures and anticonvulsant agents on hippocampal RNA concentration.
    Tannhauser M; Izquierdo I
    Pharmacology; 1974; 11(3):139-45. PubMed ID: 4831802
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticonvulsive properties of some derivatives of benzodiazepine].
    Vikhliaev IuI; Klygul' TA; Astakhova AV
    Farmakol Toksikol; 1970; 33(2):149-54. PubMed ID: 5425619
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative activity of delta9-tetrahydrocannabinol, diphenylhydantoin, phenobarbital and chlordiazepoxide on electroshcok seizure threshold in mice.
    Sofia RD; Barry H
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):73-8. PubMed ID: 921404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effects of phenytoin and phenobarbital on electrically induced maximal seizures in frogs and mice.
    Johnson SW; Riker WK
    J Pharmacol Exp Ther; 1982 Apr; 221(1):132-8. PubMed ID: 6977640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin.
    Chesher GB; Jackson DM
    Psychopharmacologia; 1974 Jul; 37(3):255-64. PubMed ID: 4850601
    [No Abstract]   [Full Text] [Related]  

  • 20. Cannabidiol interaction with delta9-tetrahydrocannabinol.
    Borgen LA; Davis WM
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):663-70. PubMed ID: 4828762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.